CJC 1295 no dac + ipamorelin

CJC-1295 (No DAC) + Ipamorelin is a combined synthetic peptide formulation consisting of a modified growth hormone-releasing hormone (GHRH) analog and a selective growth hormone secretagogue. CJC-1295 (No DAC) is a short-acting peptide fragment designed without Drug Affinity Complex (DAC) modification, while Ipamorelin is a pentapeptide known for its targeted interaction with ghrelin receptors.

In laboratory environments, this peptide combination is frequently examined for its coordinated activity within growth hormone signaling pathways and receptor-mediated processes. Researchers often study the interaction between GHRH analogs and ghrelin receptor agonists in experimental models related to endocrine regulation, peptide synergy, and cellular signaling mechanisms.

Due to their complementary structures and well-characterized receptor interactions, CJC-1295 (No DAC) and Ipamorelin are commonly referenced in peptide chemistry and molecular biology research. This combination serves as a useful subject in controlled investigations exploring peptide signaling dynamics and biochemical regulatory systems.

This product is supplied strictly for laboratory research purposes only. It is not intended for human or animal consumption, medical use, or diagnostic applications.